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Summary Although atopic dermatitis is known to be closely associated with food antigens,
the actual changes in the gastrointestinal tract have not been clarified. The aim of this study
was to investigate the macroscopic and histological features of the large intestine in patients
with atopic dermatitis. We studied 15 outpatients who had generalized atopic dermatitis. Eight
non-dermatitis subjects of a similar age without inflammatory bowel disease were also
enrolled as controls. Total colonoscopy, pathological evaluation of biopsy specimens, and
detection of Candida albicans were performed in all subjects. Four patients were re-examined
after 6 months of treatment with an antifungal drug. Among the 15 patients with atopic
dermatitis, 4 patients had melanosis coli. On pathological examinations, prominent infiltration
of eosinophils and fragmentation of granulocyte nuclei were observed. There were no changes
after an antifungal therapy. In the patients with melanosis coli, lipofuscin deposits were
observed in the lamina propria. Candida albicans was not detected in any of the subjects. In
conclusion, patients with atopic dermatitis may have a predisposition to develop chronic
inflammation of the large intestine.
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Introduction
Recently, adult atopic dermatitis has increased rapidly in
Japan. Although various factors contribute to the development
of atopic dermatitis, food allergy has attracted attention and
the contribution of food antigens to disease is considered
to be important [1–5]. Treatment of atopic dermatitis by
removing certain food antigens from the diet has shown
some clinical success [6–10].
On the other hand, since Crook et al. proposed the “Yeast
Connection” [11,  12], many reports have suggested that
mycosis may be associated with atopic dermatitis [13–19] and
some previous studies have demonstrated that administration
of antifungal agents is effective for improving this type of
dermatitis [20–22]. However, it is still unclear whether or
not intestinal candidiasis plays a role in atopic dermatitis.
Although an association between the digestive tract and
atopic dermatitis has long been assumed, there have been
few direct studies of the digestive tract in patients with this
condition [23]. In order to determinate the state of the diges-
tive tract in patients with atopic dermatitis, and whether
mycosis intestinalis plays a role in this condition, a direct
investigation of the digestive tract in outpatients without
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specific abdominal symptoms is considered to be necessary.
We examined the large intestine in atopic dermatitis
patients without specific abdominal symptom to clarify the
gross and histological features of the large bowel in this
condition. The possible contribution of intestinal candidiasis
to atopic dermatitis was also studied.
Materials and Methods
Patients
Atopic dermatitis patients attending Aichi Medical
University Hospital or Hoshigaoka Dermatology Clinic over
the past several years were enrolled this study. Their average
age was 26.1 ± 2.3 years and the male to female ratio was
13:2. All patients were in a good general condition, but had
eruptions with areas of lichenification and exudation, skin
pigmentation, and epilation distributed over the entire body.
The bowel habits of all patients were normal. They had no
specific abdominal symptoms and did not abuse laxatives
that containing senna, aloe, or other ingredients. All patients
were being treated with anti allergy agents and occasionally
used topical preparations containing corticosteroids. They
had not taken oral steroids for at least 3 months before
enrollment. As a control group, 2 healthy adult volunteers
and 6 subjects with no atopic dermatitis who complained of
abdominal symptoms such as constipation but did not have
inflammatory bowel disease on colonoscopy also participated
in this study. Their average age was 23.4 ± 2 years and
the male to female ratio was 7:1. Endoscopic examination
of the large intestine was performed at endoscopy center
of Nagoya University Hospital after obtaining a written
informed consent. An antifungal drug (itraconazole  at
100 mg/day, Janssen Pharmaceutical K.K., Tokyo, Japan)
was administered to 4 dermatitis patients for 6 months, and
endoscopic examination was performed again at the time
when skin eruptions had improved.
Colonoscopy and Preparation of Biopsy Specimens
The subjects fasted with free access to water from the
morning of examination. They each drank 2 L of Niflec (a
polyethylene glycol electrolyte solution, Ajinomoto Pharma
Co. Ltd., Tokyo, Japan) over 2 hours from 9:00 a.m., and
examinations were started at 1:30 p.m.. As premedication,
20 mg of scopolamine butylbromide was administered intra-
muscularly. The colonoscope was inserted to as far as the
coecum and observation was performed with drawing it.
Biopsy specimens were taken randomly from the distal
descending colon, when localized lesion was not observed.
One part of each specimen was fixed in 10% buffered
formalin and embedded in paraffin. The other part was fixed
in 4% paraformaldehyde for 6 h, immersed in 20% sucrose/
PBS solution for 30 min., embedded in OCT compound, and
frozen at −80°C.
Histological Evaluation
Eosinophil infiltration was classified into 4 grades from 0
to 3+ (0: almost none, 1+: slight, 2+: moderate, 3+: severe)
by examination of hematoxylin-eosin stained 3-µm sections
of paraffin-embedded specimens. Classification was done by
pathologists without access to any clinical information, as
previously reported [24]. Fragmentation of granulocyte nuclei
and lipofuscin deposits were also evaluated in the same manner.
Detection of Candida Albicans
Detection of Candida albicans was performed by immuno-
histochemical staining of 5-µm frozen sections using the
streptavidin-biotin method. The primary antibody was anti-
Candida albicans mouse monoclonal antibody (Chemicon
International. Inc., Temecula, CA). In addition, DNA was
extracted from 10-µm frozen sections using DNAzol
(Molecular Research Center Inc., Cincinnati, OH) and
PCR with a specific primer set for the secretory aspartate
proteinase of Candida albicans was performed under the
conditions shown in Table 1.
Statistical Analysis
Values are expressed as the mean ± S.E. The Wilcoxon’s
rank test was used for assessment of differences in patho-
logical features and p<0.05 was considered significant.
Results
Endoscopic Findings
Total colonoscopy could be performed without any problems
in all cases. In the patients with atopic dermatitis, the long
sigmoid colon is commonly coiled inside the pelvis.
Macroscopically, no abnormal findings were observed in
the control group, whereas marked melanosis coli were
found in 4 of the 15 patients with atopic dermatitis (Fig. 1).
After treatment with an antifungal drug for 6 months, there
was no change in the extent of melanosis coli (Fig. 1),
although the skin eruptions showed improvement.
Histological Findings
Table 2 summarized the results of histological examination.
Eosinophil infiltration and granulocyte nuclear fragments
Table 1. Condition for PCR to detect the secretory aspartate pro-
teinase of Candida albicans.
Forward 5'-TTGCCGATATCACCAAGACTTCTATTCCTC-3'
Reverse 5'-TGAGAGAATTCAAAGTGATTCTTAATTCTC-3'
Denaturation 94°C 60 sec.
Annealing 58°C 40 sec.
Extension 72°C 45 sec.
40 cycles
A 273-bp product was obtaind by this PCR reaction.T. Arisawa et al.
J. Clin. Biochem. Nutr.
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Fig. 1.  Endoscopic features of melanosis coli. The ascending colon (a) and descending colon (b) of patient no. 8, and the transverse co-
lon of patient no. 13 before (c) and after (d) treatment with itraconazole.
Table 2. Histological findings of the large intestine in both groups.
Subject 
no. Age Sex
Peripheral 
Eosinophil
count (/µL)
Total IgE 
level (IU/mL)
Eosinophilil 
infiltrations
Nuclear 
fragments
Lipofuscin 
deposits
1 28 M 984 23000 3+ 2+ -
·2* 38 M 448 23000 3+ 2+ 2+
3 22 M 610 15000 3+ 2+ -
4 24 M 279 13000 3+ 2+ -
·5 20 M 972 13000 3+ 2+ +
6* 20 M 760 10270 2+ + -
7 33 M 324 10000 + - -
·8* 23 M 451 8200 + + 2+
9 23 M 682 6700 2+ + -
10 18 M 702 6610 + - -
11* 26 M 532 5300 2+ + -
12 19 M 592 4400 2+ + -
·13 37 F 913 4200 2+ + +
14 47 F 310 2900 2+ + -
15 14 M 798 1500 2+ 2+ -
C1 26 M + + -
C2 21 M - - -
C3 20 M + + -
C4 18 M + + -
C5 17 M + - -
C6 22 F - - -
V1 30 M + - -
V2 33 M + - -
1–15: Patients with atopic dermatitis, C1–6: Controls, V1,2: Volunteers
*: Repeat colonoscopy was performed after 6 months of treatment with itraconazol.
·: Cases with melanosis coli.Atopic Dermatitis and Colon
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were significantly more common in the atopic dermatitis
group than the control group (both p<0.05, Figs. 2 and 3).
There was no relationship between the peripheral blood
eosinophil count and the extent of eosinophil infiltration
into the colonic mucosa. In the patients with melanosis coli,
lipofuscin deposits were also observed in the lamina propria
(Fig. 3). The total IgE level showed no association with any
of these histological findings. The histological changes did
not improve in any of the 4 patient cases after treatment with
an antifungal drug for 6 months, although skin eruptions
were alleviated.
Candida albicans
On histochemical and genetic analysis, Candida albicans
was not detected in any of the subjects (Fig. 4). The same
result was also obtained after antifungal therapy.
Discussion
This is the first study to directly investigate the charac-
teristics of large intestine in patients with atopic dermatitis.
Macroscopically, there were no abnormal findings in 11 of
over 15 patients, whereas prominent melanosis coli were
seen in the other 4 patients (26.7%). This prevalence was
far higher than that reported by Watanabe et al. [25] (57
cases of melanosis coli in 6,293 persons undergoing routine
proctosigmoidscopy). It is generally recognized that melanosis
coli are observed in elderly persons who have a history of
chronic laxative use [26–28]. However, our patients were
so young, had no abdominal symptoms, and no history of
laxative abuse.
The melanosis reflects the lipofuscin depositions in mucosa
pathologically, and these lipofuscin depositions induced by the
binding of lipid hydroperoxides to proteins is understandable
Fig. 2.  Histological findings of biopsy specimens from the descending colon in patients with atopic dermatitis. Numerous eosinophil
are infiltrating into the lamina propuria (a). A cluster of eosinophil (b) and fragments of granulocyte nuclei are observed (c). In
association with melanosis coli, lipofuscin deposits are seen (d).
Fig. 3.  Histological scores. In the atopic dermatitis group, the
scores for both eosinophil infiltration and fragmentation
of granulocyte nuclei were significantly higher than in
the control group. Values are shown as the mean ± SE.
* p<0.05.T. Arisawa et al.
J. Clin. Biochem. Nutr.
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to be findings with aging [29–32]. On the other hand,
melanosis is also considered to be a sign of chronic inflam-
mation [27, 33–35]. Indeed, melanosis coli is reported to be
associated with inflammatory bowel diseases [36]. Because
pathological findings, such as eosinophil infiltration and frag-
mentation of granulocyte nuclei, were seen in our patients
with atopic dermatitis, the melanosis coli observed in this
study may be caused by chronic inflammation. Recently,
Niwa et al. have been reported that atopic dermatitis is part
of the spectrum of diseases related to impaired epithelial
barriers and may be associated with ulcerative colitis [37].
Further, it was reported that hypoproteinemia as a complication
of severe atopic dermatitis was caused by loss of protein
through the gastrointestinal tract [38]. Thus, although neither
erosions nor ulceration were observed in our study, latent
chronic inflammation may be present in the large intestine of
atopic dermatitis patients.
However, this inflammation may not be a cause of atopic
dermatitis because there was no improvement of melanosis
coli or inflammatory cell infiltration over 4 patients, whose
dermatitis improved after 6 months of treatment with an
antifungal drug. This finding also suggested that there was
little association between intestinal candidiasis and chronic
inflammation of the large intestine. In the present study, we
attempted to detect Candida albicans in the colonic mucosa
using PCR and immunohistochemistry of biopsy specimens.
Although these methods are very sensitive, it is impossible
to assess the entire large intestine, so false-negative results
may be obtained. It might be suggested that we should
have used fecal culture, but we employed these methods
in order to avoid the risk of contamination. Our study
revealed no Candida albicans in all the 15 patients. In 4
patients who underwent treatment with an antifungal drug,
Candida albicans was also not detected after treatment.
These results provide further evidence of the lack of an
association between Candida albicans and endoscopic and
histological changes of the colon in patients with atopic
dermatitis.
Conclusions
The present prospective study suggested that patients with
atopic dermatitis might have an latent chronic inflammation
in the large intestine, although this was not a strict case-
control study. In addition, Candida albicans seems to have
little influence on chronic inflammation of the large intestine.
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